Interaction of norepinephrine with subcellular fractions of rat brain. I. Characteristics of norepinephrine uptake.
D000818:Animals; D001921:Brain / Q000201:enzymology / Q000378:metabolism*; D001923:Brain Chemistry / Q000187:drug effects*; D002247:Carbon Isotopes; D002474:Cell-Free System; D002499:Centrifugation, Density Gradient; D002802:Cholinesterases / Q000378:metabolism; D004878:Ergotamine / Q000494:pharmacology; D006213:Hallucinogens / Q000494:pharmacology; D008928:Mitochondria / Q000378:metabolism*; D009411:Nerve Endings / Q000378:metabolism*; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000378:metabolism*; D011562:Psilocybin / Q000494:pharmacology; D011748:Pyrogallol / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000494:pharmacology; D013385:Succinate Dehydrogenase / Q000378:metabolism; D014166:Transferases / Q000378:metabolism
D002247:Carbon Isotopes; D006213:Hallucinogens; D011748:Pyrogallol; D011562:Psilocybin; D012701:Serotonin; D013385:Succinate Dehydrogenase; D014166:Transferases; D002802:Cholinesterases; D004878:Ergotamine; D009638:Norepinephrine